| Dr Dominic John Valentino Iii, DO | |
|
239 Hurffville Crosskeys Rd, Ste 450, Sewell, NJ 08080 | |
| (856) 341-8390 | |
| Not Available |
| Full Name | Dr Dominic John Valentino Iii |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 23 Years |
| Location | 239 Hurffville Crosskeys Rd, Sewell, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215088067 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Christiana Hospital | Newark, DE | Hospital |
| Mercy Catholic Medical Center- Mercy Fitzgerald | Darby, PA | Hospital |
| Beebe Medical Center | Lewes, DE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Critical Care Physicians Of Pennsylvania Pc | 2466610498 | 41 |
| Christiana Care Health Services Inc | 9739097569 | 1248 |
News Archive
The White House has apparently decided that it won't enforce the unpopular parts of its health-care plan until after the 2012 election. The latest evidence is its decision not to slash Medicare Advantage, the program that Democrats hate because it lets seniors choose private insurance options. ... Would this be the same Medicare Advantage that candidate Barack Obama vowed to eliminate, saying in 2007 that "We shouldn't be rewarding the insurance industry for deceiving and defrauding our seniors"? (2/25).
The U.S. Food and Drug Administration today is extending the indication of Ibrance (palbociclib) capsules in combination with specific endocrine therapies for hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in male patients.
Some 5.8 million Americans suffer from heart failure, a currently incurable disease. But scientists at Temple University School of Medicine's (TUSM) Center for Translational Medicine have discovered a key biochemical step underlying the condition that could aid the development of new drugs to treat and possibly prevent it.
In an article published ahead of print on November 24, 2015 in the journal Diabetes (available at http://dx.doi.org/10.2337/db15-0930), researchers from the Medical University of South Carolina, the American University of Beirut, and Case Western Reserve University report that a molecule called pre-kallikrein (PK) could be a target for the vascular complications associated with type 1 diabetes.
Androgen deprivation therapy for the treatment of prostate cancer can lead to loss of muscle and bone mass.
› Verified 1 days ago
| Entity Name | Critical Care Physicians Of Pennsylvania Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952670085 PECOS PAC ID: 2466610498 Enrollment ID: O20120222000844 |
News Archive
The White House has apparently decided that it won't enforce the unpopular parts of its health-care plan until after the 2012 election. The latest evidence is its decision not to slash Medicare Advantage, the program that Democrats hate because it lets seniors choose private insurance options. ... Would this be the same Medicare Advantage that candidate Barack Obama vowed to eliminate, saying in 2007 that "We shouldn't be rewarding the insurance industry for deceiving and defrauding our seniors"? (2/25).
The U.S. Food and Drug Administration today is extending the indication of Ibrance (palbociclib) capsules in combination with specific endocrine therapies for hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in male patients.
Some 5.8 million Americans suffer from heart failure, a currently incurable disease. But scientists at Temple University School of Medicine's (TUSM) Center for Translational Medicine have discovered a key biochemical step underlying the condition that could aid the development of new drugs to treat and possibly prevent it.
In an article published ahead of print on November 24, 2015 in the journal Diabetes (available at http://dx.doi.org/10.2337/db15-0930), researchers from the Medical University of South Carolina, the American University of Beirut, and Case Western Reserve University report that a molecule called pre-kallikrein (PK) could be a target for the vascular complications associated with type 1 diabetes.
Androgen deprivation therapy for the treatment of prostate cancer can lead to loss of muscle and bone mass.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dominic John Valentino Iii, DO 1500 Lansdowne Ave, Ms-044, Darby, PA 19023-1200 Ph: (610) 237-7337 | Dr Dominic John Valentino Iii, DO 239 Hurffville Crosskeys Rd, Ste 450, Sewell, NJ 08080 Ph: (856) 341-8390 |
News Archive
The White House has apparently decided that it won't enforce the unpopular parts of its health-care plan until after the 2012 election. The latest evidence is its decision not to slash Medicare Advantage, the program that Democrats hate because it lets seniors choose private insurance options. ... Would this be the same Medicare Advantage that candidate Barack Obama vowed to eliminate, saying in 2007 that "We shouldn't be rewarding the insurance industry for deceiving and defrauding our seniors"? (2/25).
The U.S. Food and Drug Administration today is extending the indication of Ibrance (palbociclib) capsules in combination with specific endocrine therapies for hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in male patients.
Some 5.8 million Americans suffer from heart failure, a currently incurable disease. But scientists at Temple University School of Medicine's (TUSM) Center for Translational Medicine have discovered a key biochemical step underlying the condition that could aid the development of new drugs to treat and possibly prevent it.
In an article published ahead of print on November 24, 2015 in the journal Diabetes (available at http://dx.doi.org/10.2337/db15-0930), researchers from the Medical University of South Carolina, the American University of Beirut, and Case Western Reserve University report that a molecule called pre-kallikrein (PK) could be a target for the vascular complications associated with type 1 diabetes.
Androgen deprivation therapy for the treatment of prostate cancer can lead to loss of muscle and bone mass.
› Verified 1 days ago
Dr. Janet Fontanella, DO Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 211 County House Rd, Sewell, NJ 08080 Phone: 856-401-7660 | |
Dr. Lisa Carlene Dimedio, D.O. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 354 Hurffville Crosskeys Rd Bldg 2, Sewell, NJ 08080 Phone: 844-542-2273 | |
Dr. Anthony Pool Scarpaci, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 Medical Center Dr Ste 200, Sewell, NJ 08080 Phone: 856-557-7900 | |
Dr. Carlos A Obregon, D.O. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 100a Kings Way West, Sewell, NJ 08080 Phone: 856-218-8080 Fax: 856-218-8070 | |
Dr. Jennifer Megan Lecomte, DO Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1474 Tanyard Road, Suite C100, Sewell, NJ 08080 Phone: 855-932-7476 Fax: 856-566-6300 | |
Dr. Sharan Parikh, DO Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Plaza Dr Ste 103, Sewell, NJ 08080 Phone: 856-642-2133 Fax: 856-642-2134 | |
David Joseph Kovalsky, DO Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 435 Hurfville-crosskeys Rd, Sewell, NJ 08012 Phone: 856-218-5634 Fax: 856-218-5664 |